Congress Questions Centre s Silence On Covaxin Pricing Controversy In Brazil Congress Questions Centre s Silence On Covaxin Pricing Controversy In Brazil Congress spokesperson Supriya Shrinate stressed it is a serious issue of corporate governance if these allegations are to be believed.
Congress said the issue brings disrepute and taint to the entire Indian pharma industry. (File)
New Delhi:
The Congress Party on Friday cornered the central government over the Covaxin pricing controversy in Brazil and asked the Centre why it is conspicuously silent on the matter.
Briefing medipersons, Congress spokesperson Supriya Shrinate said, It is important for us to raise these questions because Bharat Biotech may be a private entity, but, the public fund was diverted for the development of this vaccine. Taxpayers money was put into this and which is why we have a right to question: what has happened with that money and why is the government conspicuously silent on it?
Congress Raises Questions Over Covaxin Deal With Brazil, Seeks Probe
thewire.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thewire.in Daily Mail and Mail on Sunday newspapers.
Congress demands probe into Covaxin row in Brazil, asks why Centre is silent on it
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.